ClinConnect ClinConnect Logo
Search / Trial NCT03643991

Decreasing Agitation in Patients With Dementia Through the Use of Weighted Blankets

Launched by MAYO CLINIC · Aug 21, 2018

Trial Information

Current as of October 14, 2025

Enrolling by invitation

Keywords

Agitation Dementia Inpatient

ClinConnect Summary

This Mayo Clinic pilot study is testing whether using a weighted blanket can help reduce agitation and other distressing symptoms in people with dementia who are in the hospital. In the study, eligible participants are randomly assigned to either receive a weighted blanket (about 10% of their body weight) for three nights with nurse supervision, or to receive usual inpatient care without a blanket. Researchers will track changes in agitation using a standard scale (CMAI) and also look at overall well‑being and other symptoms (using ESAS-r and CGI). The study is designed so participants and staff know which treatment is being given (no masking).

Who may be eligible? Adults aged 60 and older with dementia (or suspected major neurocognitive disorder) who show agitation or aggression and have a legally authorized representative who can consent. Exclusions include conditions that might be worsened by the blanket (like severe pain), inability to remove the blanket, skin injuries, or certain admission holds. If eligible, you’d sign consent, undergo baseline assessments, wear the weighted blanket for three nights with daily checks, and have a final assessment after the intervention. The trial is based at Mayo Clinic in Rochester, Minnesota, plans to enroll about 30 people, started in 2018, and is currently enrolling by invitation with completion expected in 2026. Results are not available yet.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients admitted on the inpatient geriatric psychiatry unit, complex interventions unit, internal medicine service and/or admitted hospice GIP
  • Documented diagnosis of dementia or suspected major neurocognitive disorder.
  • Presence of agitation/aggression symptoms as defined by a minimum aggression score on the Cohen-Mansfield Agitation Inventory Short Version (CMAI): Patients must score 3, 4, or 5 on at least one question related to aggression (items 1-4).
  • Have a LAR able to sign the consent on behalf of the patient.
  • Exclusion Criteria:
  • Severe pain likely to be exacerbated by use of weighted blanket
  • Inability to remove blanket;
  • Skin burns or open wounds;
  • Admitted on 72 hour hold.

About Mayo Clinic

Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.

Locations

Rochester, Minnesota, United States

Patients applied

0 patients applied

Trial Officials

Maria Lapid, MD

Principal Investigator

Mayo Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials